Other
Other income, net (Note 6)
United Therapeutics Other income, net (Note 6) decreased by 198.1% to -$46.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 976.7%, from -$4.30M to -$46.30M. Over 2 years (FY 2022 to FY 2025), Other income, net (Note 6) shows an upward trend with a 10.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionOther
CategoryOther
SignalHigher is better
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026May 6, 2026
How to read this metric
Positive values indicate non-core gains, while negative values indicate non-core losses or interest burdens.
Detailed definition
This captures income or expenses that are not part of the company's core business operations, such as interest income, f...
Peer comparison
Standard line item found in the non-operating section of the income statement for most corporations.
Metric ID:
other_other_nonoperating_income_expenseHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$2.70M | -$23.50M | $22.80M | -$51.80M | -$5.90M | -$5.30M | -$7.90M | -$600.00K | -$4.90M | -$600.00K | $1.80M | $800.00K | $5.80M | -$4.30M | -$100.00K | $6.10M | $47.20M | -$46.30M |
| QoQ Change | — | -770.4% | +197.0% | -327.2% | +88.6% | +10.2% | -49.1% | +92.4% | -716.7% | +87.8% | +400.0% | -55.6% | +625.0% | -174.1% | +97.7% | >999% | +673.8% | -198.1% |
| YoY Change | — | — | — | <-999% | +74.9% | — | -134.6% | +98.8% | +16.9% | +88.7% | +122.8% | +233.3% | +218.4% | -338.9% | -112.5% | +5.2% | — | -976.7% |
Range-$51.80M – $47.20M
CAGR+95.2%
Avg YoY Growth-194.0%
Median YoY Growth+16.9%
Other income, net (Note 6) at Other Companies
Frequently Asked Questions
- What is United Therapeutics's other income, net (note 6)?
- United Therapeutics (UTHR) reported other income, net (note 6) of -$46.30M in Q1 2026.
- How has United Therapeutics's other income, net (note 6) changed year-over-year?
- United Therapeutics's other income, net (note 6) decreased by 976.7% year-over-year, from -$4.30M to -$46.30M.
- What is the long-term trend for United Therapeutics's other income, net (note 6)?
- Over 2 years (2022 to 2025), United Therapeutics's other income, net (note 6) has grown at a 10.3% compound annual growth rate (CAGR), from -$40.20M to $48.90M.
- What does other income, net (note 6) mean?
- Financial gains or losses that fall outside of the company's primary business activities.